INS and Stroke: In regard to safety, long-term studies on transgender men have shown that even higher (male) doses of T do not increase the risk of cardiovascular events, stroke, or cancer; T therapy also increases insulin sensitivity, as opposed to estrogen therapy in transgender women [32, 37, 38].